BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maltby VE, Lea RA, Ribbons KA, Sanders KA, Kennedy D, Min M, Scott RJ, Lechner-Scott J. DNA methylation changes in CD4+ T cells isolated from multiple sclerosis patients on dimethyl fumarate. Mult Scler J Exp Transl Clin 2018;4:2055217318787826. [PMID: 30038789 DOI: 10.1177/2055217318787826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Campagna MP, Xavier A, Stankovich J, Maltby V, Slee M, Kilpatrick T, Scott RJ, Butzkueven H, Lechner-scott J, Lea R, Jokubaitis V. Birth history is associated with whole-blood and T-cell methylation patterns in relapse onset multiple sclerosis.. [DOI: 10.1101/2022.03.24.22272917] [Reference Citation Analysis]
2 Roostaei T, Klein HU, Ma Y, Felsky D, Kivisäkk P, Connor SM, Kroshilina A, Yung C, Kaskow BJ, Shao X, Rhead B, Ordovás JM, Absher DM, Arnett DK, Liu J, Patsopoulos N, Barcellos LF, Weiner HL, De Jager PL. Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome. Nat Commun 2021;12:7078. [PMID: 34873174 DOI: 10.1038/s41467-021-27427-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
3 Campagna MP, Xavier A, Lechner-Scott J, Maltby V, Scott RJ, Butzkueven H, Jokubaitis VG, Lea RA. Epigenome-wide association studies: current knowledge, strategies and recommendations. Clin Epigenetics 2021;13:214. [PMID: 34863305 DOI: 10.1186/s13148-021-01200-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
4 Maltby VE, Lea RA, Monif M, Fabis-Pedrini MJ, Buzzard K, Kalincik T, Kermode AG, Taylor B, Hodgkinson S, McCombe P, Butzkueven H, Barnett M, Lechner-Scott J. Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study). JMIR Res Protoc 2021;10:e24969. [PMID: 34665152 DOI: 10.2196/24969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kiselev IS, Kulakova OG, Boyko AN, Favorova OO. DNA Methylation As an Epigenetic Mechanism in the Development of Multiple Sclerosis. Acta Naturae 2021;13:45-57. [PMID: 34377555 DOI: 10.32607/actanaturae.11043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wei H, Wang JY. Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis. Int J Mol Sci 2021;22:2284. [PMID: 33668983 DOI: 10.3390/ijms22052284] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
7 Maltby VE, Lea RA, Monif M, Fabis-pedrini MJ, Buzzard K, Kalincik T, Kermode AG, Taylor B, Hodgkinson S, Mccombe P, Butzkueven H, Barnett M, Lechner-scott J. Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study) (Preprint).. [DOI: 10.2196/preprints.24969] [Reference Citation Analysis]
8 Vakhitov VA, Kuzmina US, Bakhtiyarova KZ, Zainullina LF, Maksimova MA, Zileeva ZR, Vakhitova YV. Epigenetic Mechanisms of the Pathogenesis of Multiple Sclerosis. Hum Physiol 2020;46:104-112. [DOI: 10.1134/s0362119720010144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]